PMID- 37761246 OWN - NLM STAT- Publisher LR - 20231003 IS - 2075-4418 (Print) IS - 2075-4418 (Electronic) IS - 2075-4418 (Linking) VI - 13 IP - 18 DP - 2023 Sep 8 TI - Peripheral Interventional Strategy Assessment (PISA) for Diabetic Foot Ulcer Revascularization: Preliminary Outcomes of a Multidisciplinary Pilot Study. LID - 10.3390/diagnostics13182879 [doi] LID - 2879 AB - BACKGROUND: Digital subtraction angiography (DSA) still represents the gold standard for anatomical arterial mapping and revascularization decision-making in patients with chronic limb-threatening ischemia (CLTI), although DUS (Doppler Ultrasound) remains a primary non-invasive examination tool. The Global Vascular Guidelines established the importance of preoperative arterial mapping to guarantee an adequate in-line flow to the foot. The aim of this study was to evaluate the accuracy of DUS in guiding therapeutic vascular treatments on the basis of Global Vascular Guidelines without the need of a second-level examination. METHODS: Between January 2022 and June 2022, all consecutive patients with CLTI to be revascularized underwent clinical examination and DUS without further diagnostic examinations. Primary outcomes assessed were technical success, and 30-day mortality. Secondary outcomes were 1-year amputation free survival, and time between evaluation and revascularization. RESULTS: Sixty-eight patients with a mean age of 73.6 +/- 8.5 years underwent lower limb revascularization. Technical success was 100%, and the 30-day mortality rate was 2.9%. Mean time between evaluation and revascularization was 29 +/- 17 days. One-year amputation free survival was 97.1%. CONCLUSIONS: DUS without further diagnostic examinations can accurately assess the status of the vascular tree and foot runoff, providing enough information about target vessels to guide revascularization strategies. FAU - Berchiolli, Raffaella AU - Berchiolli R AD - Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy. FAU - Bertagna, Giulia AU - Bertagna G AUID- ORCID: 0000-0003-1363-489X AD - Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy. FAU - Adami, Daniele AU - Adami D AD - Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy. FAU - Piaggesi, Alberto AU - Piaggesi A AD - Diabetic Foot Section, Department of Medicine, University of Pisa, 56126 Pisa, Italy. FAU - Iacopi, Elisabetta AU - Iacopi E AD - Diabetic Foot Section, Department of Medicine, University of Pisa, 56126 Pisa, Italy. FAU - Giangreco, Francesco AU - Giangreco F AD - Diabetic Foot Section, Department of Medicine, University of Pisa, 56126 Pisa, Italy. FAU - Torri, Lorenzo AU - Torri L AUID- ORCID: 0000-0002-1587-2763 AD - Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy. FAU - Troisi, Nicola AU - Troisi N AUID- ORCID: 0000-0002-8779-9120 AD - Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy. LA - eng PT - Journal Article DEP - 20230908 PL - Switzerland TA - Diagnostics (Basel) JT - Diagnostics (Basel, Switzerland) JID - 101658402 PMC - PMC10528535 OTO - NOTNLM OT - chronic limb-threatening ischemia OT - duplex ultrasonography OT - lower limb revascularization COIS- The authors declare no conflict of interest. EDAT- 2023/09/28 06:43 MHDA- 2023/09/28 06:43 PMCR- 2023/09/08 CRDT- 2023/09/28 01:11 PHST- 2023/07/27 00:00 [received] PHST- 2023/08/28 00:00 [revised] PHST- 2023/09/07 00:00 [accepted] PHST- 2023/09/28 06:43 [medline] PHST- 2023/09/28 06:43 [pubmed] PHST- 2023/09/28 01:11 [entrez] PHST- 2023/09/08 00:00 [pmc-release] AID - diagnostics13182879 [pii] AID - diagnostics-13-02879 [pii] AID - 10.3390/diagnostics13182879 [doi] PST - epublish SO - Diagnostics (Basel). 2023 Sep 8;13(18):2879. doi: 10.3390/diagnostics13182879.